Inhibitor of 5-lipoxygenase, zileuton, suppresses prostate cancer metastasis by upregulating E-cadherin and paxillin

Urology

Volumn 82, Issue 6, 2013, Pages 1452.e7-1452.e14

  Meng, Zhe ^a   Cao, Rui ^a   Yang, Zhonghua ^a   Liu, Tao ^a   Wang, Yongzhi ^a   Wang, Xinghuan ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; PAXILLIN; UVOMORULIN; ZILEUTON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CANCER CELL; CANCER SIZE; CANCER SURVIVAL; CELL CYCLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LIFESPAN; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CADHERINS; CELL MIGRATION ASSAYS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; HYDROXYUREA; IMMUNOHISTOCHEMISTRY; LIPOXYGENASE INHIBITORS; MALE; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; PAXILLIN; PROSTATIC NEOPLASMS; UP-REGULATION;

EID: 84888610540     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.08.060     Document Type: Article

References (29)

1. D. Ilic, M.M. Neuberger, and M. Djulbegovic Screening for prostate cancer Cochrane Database Syst Rev 1 2013 CD004720
2. W. Wang, A. Bergh, and J.E. Damber Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer Clin Cancer Res 11 2005 3250 3256
3. W.G. Nelson, A.M. De Marzo, and T.L. DeWeese The role of inflammation in the pathogenesis of prostate cancer J Urol 172 2004 S6 S11 [discussion S11-S2]
4. O. Werz, and D. Steinhilber Therapeutic options for 5-lipoxygenase inhibitors Pharmacol Ther 112 2006 701 718
5. O. Radmark, O. Werz, and D. Steinhilber 5-Lipoxygenase: regulation of expression and enzyme activity Trends Biochem Sci 32 2007 332 341
6. G. Furstenberger, P. Krieg, and K. Muller-Decker What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer 119 2006 2247 2254
7. D. Wang, and R.N. Dubois Eicosanoids and cancer Nat Rev Cancer 10 2010 181 193
8. S. Gupta, M. Srivastava, and N. Ahmad Lipoxygenase-5 is overexpressed in prostate adenocarcinoma Cancer 91 2001 737 743
9. S. Sarveswaran, C.E. Myers, and J. Ghosh MK591, a leukotriene biosynthesis inhibitor, induces apoptosis in prostate cancer cells: synergistic action with LY294002, an inhibitor of phosphatidylinositol 3′-kinase Cancer Lett 291 2010 167 176
10. S. Sarveswaran, V. Thamilselvan, C. Brodie, and J. Ghosh Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon Biochim Biophys Acta 1813 2011 2108 2117
11. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
12. A. Mantovani Cancer: inflammation by remote control Nature 435 2005 752 753
13. R. Hennig, J. Ventura, and R. Segersvard LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice Neoplasia 7 2005 417 425
14. S. Paruchuri, O. Broom, and K. Dib The pro-inflammatory mediator leukotriene D4 induces phosphatidylinositol 3-kinase and Rac-dependent migration of intestinal epithelial cells J Biol Chem 280 2005 13538 13544
15. D. Nie, Y. Guo, and D. Yang Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho Cancer Res 68 2008 115 121
16. J.M. Drazen, E. Israel, and P.M. O'Byrne Treatment of asthma with drugs modifying the leukotriene pathway N Engl J Med 340 1999 197 206
17. W. Berger, M.T. De Chandt, and C.B. Cairns Zileuton: clinical implications of 5-lipoxygenase inhibition in severe airway disease Int J Clin Pract 61 2007 663 676
18. T. Genovese, A. Rossi, and E. Mazzon Effects of zileuton and montelukast in mouse experimental spinal cord injury Br J Pharmacol 153 2008 568 582
19. S. Cuzzocrea, A. Rossi, and E. Mazzon 5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration Lab Invest 85 2005 808 822
20. M. Collin, A. Rossi, and S. Cuzzocrea Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton J Leukoc Biol 76 2004 961 970
21. J.I. Gregor, M. Kilian, and I. Heukamp Effects of selective COX-2 and 5-LOX inhibition on prostaglandin and leukotriene synthesis in ductal pancreatic cancer in Syrian hamster Prostaglandins Leukot Essent Fatty Acids 73 2005 89 97
22. N. Li, S. Sood, and S. Wang Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib Clin Cancer Res 11 2005 2089 2096
23. H. Shiozaki, H. Oka, and M. Inoue E-cadherin mediated adhesion system in cancer cells Cancer 77 1996 1605 1613
24. A.T. Chan, S. Ogino, and C.S. Fuchs Aspirin use and survival after diagnosis of colorectal cancer JAMA 302 2009 649 658
25. G. Bannenberg, S.E. Dahlen, and M. Luijerink Leukotriene C4 is a tight-binding inhibitor of microsomal glutathione transferase-1: effects of leukotriene pathway modifiers J Biol Chem 274 1999 1994 1999
26. W.P. Beierschmitt, J.D. McNeish, and R.J. Griffiths Induction of hepatic microsomal drug-metabolizing enzymes by inhibitors of 5-lipoxygenase (5-LO): studies in rats and 5-LO knockout mice Toxicol Sci 63 2001 15 21
27. H.J. Hussey, and M.J. Tisdale Inhibition of tumour growth by lipoxygenase inhibitors Br J Cancer 74 1996 683 687
28. S.H. Lee, M.V. Williams, and R.N. DuBois Targeted lipidomics using electron capture atmospheric pressure chemical ionization mass spectrometry Rapid Commun Mass Spectrom 17 2003 2168 2176
29. D.P. Rose, and J.M. Connolly Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids Nutr Cancer 37 2000 119 127